| Symbol |
Name |
Standardized Value |
|
ODC1
|
ornithine decarboxylase 1
|
-2.13
|
|
BAIAP2
|
BAI1-associated protein 2
|
-2.0
|
|
DUSP6
|
dual specificity phosphatase 6
|
-1.73
|
|
VSIR
|
V-set immunoregulatory receptor
|
-1.59
|
|
PRKCD
|
protein kinase C, delta
|
-1.58
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
-1.51
|
|
JAG1
|
jagged 1
|
-1.48
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
-1.45
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
-1.43
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
-1.43
|
|
NGFR
|
nerve growth factor receptor
|
-1.41
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
-1.29
|
|
GLCCI1
|
glucocorticoid induced 1
|
-1.29
|
|
PHETA1
|
PH domain containing endocytic trafficking adaptor 1
|
-1.28
|
|
PRKCQ
|
protein kinase C, theta
|
-1.23
|
|
N4BP1
|
NEDD4 binding protein 1
|
-1.23
|
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2
|
-1.21
|
|
IFFO1
|
intermediate filament family orphan 1
|
-1.2
|
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
|
-1.15
|
|
B3GNT2
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
|
-1.12
|
|
CCPG1
|
cell cycle progression 1
|
-1.1
|
|
B4GALT5
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5
|
-1.09
|
|
RPS6KA4
|
ribosomal protein S6 kinase, 90kDa, polypeptide 4
|
-1.07
|
|
WWC1
|
WW and C2 domain containing 1
|
-1.07
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
-1.05
|
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5
|
-1.04
|
|
WWC3
|
WWC family member 3
|
-1.04
|
|
MYO10
|
myosin X
|
-1.03
|
|
ZRANB1
|
zinc finger, RAN-binding domain containing 1
|
-1.01
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
-0.99
|
|
RHPN2
|
rhophilin, Rho GTPase binding protein 2
|
-0.99
|
|
HOXB4
|
homeobox B4
|
-0.97
|
|
RAB19
|
RAB19, member RAS oncogene family
|
-0.96
|
|
AMD1
|
adenosylmethionine decarboxylase 1
|
-0.95
|
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
-0.94
|
|
ZNF417
|
zinc finger protein 417
|
-0.94
|
|
DNAJB12
|
DnaJ (Hsp40) homolog, subfamily B, member 12
|
-0.93
|
|
FBXW8
|
F-box and WD repeat domain containing 8
|
-0.92
|
|
TTN
|
titin
|
-0.92
|
|
CCNF
|
cyclin F
|
-0.91
|
|
DNAJB14
|
DnaJ (Hsp40) homolog, subfamily B, member 14
|
-0.91
|
|
SH3RF1
|
SH3 domain containing ring finger 1
|
-0.89
|
|
SYT1
|
synaptotagmin I
|
-0.87
|
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
-0.86
|
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1
|
-0.86
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
-0.86
|
|
MFSD14B
|
major facilitator superfamily domain containing 14B
|
-0.86
|
|
MACC1
|
metastasis associated in colon cancer 1
|
-0.85
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
-0.85
|
|
NES
|
nestin
|
-0.84
|
|
WBP2
|
WW domain binding protein 2
|
-0.82
|
|
PRRG1
|
proline rich Gla (G-carboxyglutamic acid) 1
|
-0.82
|
|
RHOBTB3
|
Rho-related BTB domain containing 3
|
-0.81
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
-0.81
|
|
TOR3A
|
torsin family 3, member A
|
-0.8
|
|
STK4
|
serine/threonine kinase 4
|
-0.8
|
|
NKIRAS1
|
NFKB inhibitor interacting Ras-like 1
|
-0.79
|
|
PRSS8
|
protease, serine, 8
|
-0.79
|
|
TSR2
|
TSR2, 20S rRNA accumulation, homolog (S. cerevisiae)
|
-0.79
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
-0.78
|
|
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit
|
-0.78
|
|
GSE1
|
Gse1 coiled-coil protein
|
-0.78
|
|
HOXB8
|
homeobox B8
|
-0.78
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
-0.78
|
|
STK3
|
serine/threonine kinase 3
|
-0.78
|
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
|
-0.78
|
|
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila)
|
-0.77
|
|
AAGAB
|
alpha- and gamma-adaptin binding protein
|
-0.77
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
-0.77
|
|
CDR2L
|
cerebellar degeneration-related protein 2-like
|
-0.76
|
|
ZCCHC2
|
zinc finger, CCHC domain containing 2
|
-0.75
|
|
ST5
|
suppression of tumorigenicity 5
|
-0.74
|
|
MID1IP1
|
MID1 interacting protein 1
|
-0.74
|
|
LYSMD3
|
LysM, putative peptidoglycan-binding, domain containing 3
|
-0.73
|
|
AKAP11
|
A kinase (PRKA) anchor protein 11
|
-0.73
|
|
HSBP1
|
heat shock factor binding protein 1
|
-0.73
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
-0.73
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
-0.72
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
-0.72
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
-0.72
|
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13
|
-0.72
|
|
KLK6
|
kallikrein-related peptidase 6
|
-0.71
|
|
CDC25C
|
cell division cycle 25C
|
-0.71
|
|
TTLL4
|
tubulin tyrosine ligase-like family member 4
|
-0.71
|
|
CDC14A
|
cell division cycle 14A
|
-0.71
|
|
CDON
|
cell adhesion associated, oncogene regulated
|
-0.71
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
-0.71
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
-0.7
|
|
LIX1L
|
Lix1 homolog (chicken) like
|
-0.7
|
|
ZFAND5
|
zinc finger, AN1-type domain 5
|
-0.7
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
-0.7
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
-0.7
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
-0.7
|
|
PCDH1
|
protocadherin 1
|
-0.68
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
-0.68
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
-0.68
|
|
ADGRF1
|
adhesion G protein-coupled receptor F1
|
-0.67
|
|
FAM53C
|
family with sequence similarity 53, member C
|
-0.67
|
|
DGKH
|
diacylglycerol kinase, eta
|
-0.67
|
|
MIEF1
|
mitochondrial elongation factor 1
|
-0.67
|